Back to search
FDAFDA · Food and drugs·Recall number D-0649-2016

Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68

Published February 10, 2016 · Recall initiated: January 11, 2016

Summary

FDA records drug Class II recall D-0649-2016, published February 10, 2016 and initiated January 11, 2016. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 116,400 bottles; Lot: Lot #: M07862, Exp 05/2018; M07865, Exp 06/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.

What to do

Voluntary: Firm initiated · Letter

Get an email if LYRICA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LYRICA
Manufacturer
Pfizer Inc.
Distributor
Nationwide and Puerto Rico
UPC
0300711012683
Lot
Lot #: M07862, Exp 05/2018; M07865, Exp 06/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68 recalled?

Yes. FDA published recall D-0649-2016 on February 10, 2016. Reported hazard: FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LYRICA. UPC: 0300711012683.